The purpose of the present study was to investigate the immune-enhancing activity of Kombucha. In immunosuppression experiment, the immune-enhancing effect of Kombucha in immunosuppressive mice was performed.It was showed that Kombucha at high and medium doses doses was able to overcome the CY-induced immunosuppression, significantly improves the body weight, the count of white blood cell, increases the thymus and spleen indices, enhances lymphocyte proliferation activity and peritoneal macrophage function, improves natural killer cells activity compared with negative control group. In addition, the different dose of Kombucha could significantly enhance the activity of alkaline phosphatase (AKP), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-PX) in blood serum. Therefore, the Kombucha could be an effective immunomodulatory agent. 2 Materials and methods 2.1 Materials and chemicals Sugar, tea, and culture of Kombucha were provided by Tianjin Qijun Biotechnology Co., Ltd. Cyclophosphamide (CY) was purchased from Jiangsu Hengrui Medicine Co. (Lianyungang, Jiangsu, China). RPMI 1640, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Dimethyl sulfoxide (DMSO), 0.1% neutral red staining solution, red blood cell lysis buffer, lipopolysaccha-ride (LPS) and Concanavalin A (ConA) were purchased from Solarbio (Science & Technology Corporation, Beijing, China). Astragalus essence oral liquid was purchased from